@BurjaBlaz

Rheumatologist in training | Translational scientist | YIG at @EUSTAR_org

 Zurich, Switzerland
Joined January 2022
  • Tweets31
  • Following147
  • Followers84
4Media
🇬🇧 #EULAR2026 starts today and #WSFAcademy has a lot planned 👀✨ 🎧 WSF Academy Podcast,Highlights at EULAR 2026 & expert interviews 🫀 Webinar on clinical abstracts at EULAR: ILD, VEDOSS,DU,PAH🔬 Webinar on basic science abstracts at EULAR🤝 Interviews with leading SSc experts
1
5
284
Blaž Burja retweeted
EUSTAR@EUSTAR_orgJun 2
🚀 #EULAR2026 starts tomorrow! 🧐Feeling lost in the program? 🎯 Here are even more #EUSTAR #Day1 highlights! 👀📅 #Rheumatology #EUSTAR #EULAR2026
1
2
209
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database - European Journal of Internal Medicine ejinme.com/article/S0953-620… @MurielElhai @EUSTAR_org

Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in...

In the large EUSTAR cohort, anti-Ro/SSA antibodies are detected in 15% of SSc patients and represent an independent risk factor for the presence and severity of ILD, particularly for cases with...

ejinme.com
1
12
Blaž Burja retweeted
EUSTAR@EUSTAR_org8 May 2025
♦️ #EUSTAR in the Spotlight at #EULAR2025♦️ 🚨The impact of the #EUSTAR 💻 and network on SSc research is clearly visible⏩1️⃣5️⃣ abstracts from EUSTAR Clinical Projects have been accepted for #EULAR2025 ⏩lnkd.in/dbRx_83J ✅ See you in Barselona
1
5
6
419
Good morning Barcelona! @eular_ARD is fully operational onsite at #EULAR2025 with an enthusiastic team of guest Social Media Editors. Follow along for live updates!
1
11
3
35
2,114
According to Mongin et.al: low-dose glucocorticosteroids as add-on to immunosuppressive therapy do not improve skin or lung fibrosis in early SSc patients. @EUSTAR_org acrjournals.onlinelibrary.wi…
2
65
🎥 In this interesting interview, Prof. @MarieEliseTruchetet, @EUSTAR_org Vice-President, discusses with @blazburja what @EUSTAR_org brought to the Eular congress in 2024. Learn about the key contributions and highlights. #EULAR2024 @Worldsclerofnd lnkd.in/d6S8yEdM
1
2
11
467
Incredibly grateful to open this year's EULAR2024 abstract plenary session with our award-winning work on anti-Ro/SSA antibodies in systemic sclerosis and contribute a piece of EUSTAR-based research to the SSc community. Props to @MurielElhai @CosimoBruni @EUSTAR_org @eular_org
1
2
21
621
Wel done @BurjaBlaz at #eular2024 🔥👏
3
11
582
Blaž Burja retweeted
EMEUNET@EMEUNET11 Jun 2024
Introducing #EMEUNETtop10abstracts winner @BurjaBlaz! In this study based on the EUSTAR cohort, he showed that anti-SSA antibodies are associated with more prevalent and more severe lung involvement in SSc. #EMEUNET #EULAR2024
1
2
10
826
Blaž Burja retweeted
EMEUNET@EMEUNET12 Nov 2023
Buzz in the poster hall at #ACR23, here with @BurjaBlaz. Photo by @KragstrupTW
1
2
21
1,080
Its a wrap! Privileged to defend my PhD on fibroblast targeting in inflammation and fibrosis. Grateful for amazing mentorship esp. to @MojcaFB w @LakotaKatja Matija Tomšič and Oliver Distler.
9
1
23
Blaž Burja retweeted
Fesca@Fscleroderma29 Jun 2022
Today is #WorldSclerodermaDay! 🌻 A day to raise awareness and show solidarity with those trying to find the light to bloom, despite living with this rare disease. We're here for you. Let's #BloomWithScleroderma today and always. Read more ▶️ tinyurl.com/3cn93hbb
19
6
50
#SclerodermaAwarenessMonth 2017-2018 index: blog.raynaudsscleroderma.co.… The last few years have shown what can happen with investment in medical research. 24 years I have lived the daily scleroderma nightmare and held on to this dream #SclerodermaFreeWorld #RaynaudsFreeWorld 🙏
3
4
#Melanoma tweeps our paper is finally out @GenomeMedicine!! Way to go @MengWan25464592 So are you taking us golfing now? #Melanoma
Meng Wang@MengWang5517 Jun 2022
Excited to have our work on the genomics of human acral and mucosal #melanomas out @GenomeMedicine We reported multiple candidate driver genes, reproducible differences between these two refractory melanoma subtypes, and interactions between driver events genomemedicine.biomedcentral…

Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes

Genome Medicine - Acral and mucosal melanomas are aggressive subtypes of melanoma, which have a significantly lower burden of somatic mutations than cutaneous melanomas, but more frequent copy...

link.springer.com
4
3
1
13
Our first JAK-pot collaboration manuscript is out in @ARD_BMJ! What is the most effective current treatment for #RA among TNFi, abatacept, IL6i and JAKi among 31,846 real-world patients? Are they stopped for different reasons? See here👉🏻bit.ly/3Qp1oe0
3
20
3
46
Are you interested in working in the "JAK-pot" collaboration (19 #RA registers) in beautiful #Geneva? We are seeking a talented and enthusiastic research fellow to work on the evaluation of the safety and effectiveness of 2nd-line therapies! 👇 @EMEUNET
EMEUNET@EMEUNET9 Jun 2022
👉 Don't forget to keep checking our website for amazing #eularEMEUNET opportunities... 💻 emeunet.eular.org/job_postin…
2
9
2
14
Honored to have the opportunity to present our awarded study on targeting skin fibrosis in systemic sclerosis at #EULAR22. Thanks to @eular_org, amazing team and great collaboration between @ukclj @Unispital_USZ
2
1
16
Ready for the fibroblast-targeting era! Thanks to @arthritisbham and @MurielElhai @Lomhol1 @Morten__Aagaard @EMEUNET #EULAR2022
2
2
10
Delighted to be taking part in this 😊
Blaž Burja@BurjaBlaz27 May 2022
Interested to hear about the future of fibroblast targeting? Welcome to join us with Prof Chris Buckley to discuss "Cross-tissue targeting of pathogenic fibroblast subsets: where do we stand?" on Thursday 2nd June! 9.30-10.30 CET live during #EULAR2022 @arthritisbham
3
10
Load more